Evaluation of DNA damage in vivo induced by combined application of cisplatin and sevoflurane

European Journal of Anaesthesiology

Volumn 25, Issue 8, 2008, Pages 642-647

  Brozovic, G ^a   Orsolic, N ^b   Knezevic, F ^a   Horvat Knezevic, A ^b   Benkovic, V ^b   Vrdoljak, D V ^a   Saric, A ^c  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Cisplatin; Comet assay; Mice; Mutagenicity tests; Sevoflurane

Indexed keywords

CISPLATIN; SEVOFLURANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EHRLICH ASCITES TUMOR; GENOTOXICITY; IN VIVO STUDY; KIDNEY CELL; LEUKOCYTE; LIVER CELL; MALE; MOUSE; MUTAGEN TESTING; NONHUMAN;

ANESTHETICS, INHALATION; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN; CARCINOMA, EHRLICH TUMOR; CISPLATIN; COMET ASSAY; DNA; DNA DAMAGE; HEPATOCYTES; KIDNEY; LEUKOCYTES; MALE; METHYL ETHERS; MICE; STATISTICS, NONPARAMETRIC;

EID: 46249103242     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021508004171     Document Type: Article

References (23)

1. Kvolik S, Glavas-Obrovac L, Sakic K, Margaretic D, Karner I. Anaesthetic implications of anticancer chemotherapy. Eur J Anaesthesiol 2003; 20: 1-13.
2. Pleuvry A. Anaesthetic relevance of drugs used to treat cancer. Anaesth Intensive Care Med 2006; 7(6): 189-192.
3. Hegarty M, Chisholm D. Chemotherapy and anaesthesia. Curr Anaesth Crit Care 2002; 13: 168-174.
4. Madias NE, Harrington JT. Platinum nephrotoxicity. Am J Med 1978; 65: 307-314.
5. Cersosimo RJ. Hepatotoxicity associated with cisplatin chemotherapy. Ann Pharmacother 1993; 27: 438-441.
6. Şardaş S, Aygün N, Gamli M et al. Use of alkaline Comet assay (single cell gel electrophoresis technique) to detect DNA damages in lymphocytes of operating room personnel occupationally exposed to anaesthetic gases. Mutat Res 1998; 418: 93-100.
7. Sardas S, Izdes S, Ozcagli E, Kanbak O, Kadioglu E. The role of antioxidant supplementation in occupational exposure to waste anaesthetic gases. Int Arch Occup Environ Health 2006; 80: 154-159.
8. Kvolik S, Glavas-Obrovac L, Bares V, Karner I. Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sci 2005; 77: 2369-2383.
9. Karabiyik L, Şardaş S, Polat U, KocabaŞ NA, Karakaya AE. Comparison of genotoxicity of sevoflurane and isoflurane in human lymphocytes studied in vivo using the comet assay. Mutat Res 2001; 492: 99-107.
10. Szyfter K, Szulc R, Mikstacki A, Stachecki I, Rydzanicz M, Jaloszyński P. Genotoxicity of inhalation anaesthetics: DNA lesions generated by sevoflurane in vitro and in vivo. J Appl Genet 2004; 45: 369-374.
11. Hack G, Karzel K. Suspension cultures of Ehrlich ascites tumor cells test system for the study of cytotoxic effects of anaesthetics. Anaesthesist 1981; 30: 88-94.
12. Hack G, Karzel K, Panthong A, Stein P. In vitro studies on the influence of volatile anaesthetics on cell number, cell volume, and cellular protein, DNA, and RNA content. Anaesthesist 1981; 30: 134-143.
13. Singh NP, Mc Coy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988; 175: 184-191.
14. McKelvey-Martin VJ, Green MHL, Schmezer P, Pool-Zobel BL, De Meo MP, Collins A. The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 1993; 288: 47-63.
15. Collins AR. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 2004; 26: 249-261.
16. Hartmann A, Agurell E, Beevers C et al. Recommendations for conducting the in vivo alkaline Comet assay. Mutagenesis 2003; 18: 45-51.
17. Kopjar N, Garaj-Vrhovac V, Milas I. Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay. Teratog Carcinog Mutagen 2002; 22: 13-30.
18. Fillastre JP, Raguenez-Viotte G. Cisplatin nephrotoxicity. Toxicol Lett 1989; 46: 163-175.
19. Lee HT, Kim M, Jan M, Emala CW. Anti-inflammatory and antinecrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells. Am J Physiol Renal Physiol 2006; 291: 67-78.
20. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 2004; 101: 1313-1324.
21. Jaloszyński P, Ta̧drowska M, Kujawski M, Wa̧sowicz M, Szulc R, Szyfter K. Genotoxicity of inhalation anesthetics (halothane, isoflurane and sevoflurane) in human lymphocytes studied in vivo and in vitro. Neoplasma 1999; 46: 20-22.
22. Reichle FM, Conzen PF. Halogenated inhalational anaesthetics. Best Pract Res Clin Anaesthesiol 2003; 17: 29-46.
23. Wozniak K, Czechowska A, Blasiak J. Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571. Chem Biol Int 2004; 147: 309-318.